PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
Clinical trial NCT00455546 · COMPLETED
Trial details
- NCT number
- NCT00455546
- Sponsor
- Anthera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.